替米沙坦
抗高血压药
杂质
过程(计算)
产量(工程)
药品
过程开发
药理学
衍生工具(金融)
化学
血压
医学
材料科学
工艺工程
内科学
计算机科学
冶金
有机化学
业务
财务
工程类
操作系统
作者
Kikkuru Srirami Reddy,Neti Srinivasan,Chinta Raveendra Reddy,Naveenkumar Kolla,Yerremilli Anjaneyulu,Sundaram Venkatraman,Apurba Bhattacharya,Vijayavitthal T. Mathad
摘要
Telmisartan (1), a substituted dibenzimidazole derivative, is an antihypertensive drug, essentially used to control blood pressure. An improved, cost-effective, and impurity-free process for telmisartan (1) suitable for large-scale production is described here by addressing various process development issues. The overall yield obtained from this newly developed process is around 50% (over five steps) compared to the literature reported process (21%, over eight steps).
科研通智能强力驱动
Strongly Powered by AbleSci AI